SKI Market

Indian Indices

Nifty

26,068.15 -124.00
(-0.47%)

Sensex

85,231.92 -400.76
( -0.47%)

Bank Nifty

58,867.70 -480.00
( -0.81%)

Nifty IT

36,885.35 -157.95
( -0.43%)

Global Indices

Nasdaq

46,275.21 501.96
(1.10%)

Dow Jones

6,624.30 64.54
(0.98%)

Hang Seng

48,653.14 -1,170.80
(-2.35%)

Nikkei 225

9,535.95 8.30
(0.09%)

Forex

USD-INR

88.50 -0.07
(-0.08%)

EUR-INR

102.33 -0.31
(-0.31%)

GBP-INR

115.99 -0.49
(-0.42%)

JPY-INR

0.57 0.00
(-0.62%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Par Drugs & Chemicals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

535341

INE04LG01015

86.4979964

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PAR

11.72

113.49

EPS(TTM)

Face Value()

Div & Yield %

7.87

Back

Mahamaya Steel Industries consolidated net profit rises 717.39% in the September 2025 quarter

Nov 14,2025

Net profit of Mahamaya Steel Industries rose 717.39% to Rs 1.88 crore in the quarter ended September 2025 as against Rs 0.23 crore during the previous quarter ended September 2024. Sales rose 21.86% to Rs 188.57 crore in the quarter ended September 2025 as against Rs 154.74 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	188.57	154.74	22
OPM %	2.69	1.89	-
PBDT	4.56	2.08	119
PBT	2.35	0.16	1369
NP	1.88	0.23	717

26,068.15 -124.00 (-0.47%)

85,231.92 -400.76 ( -0.47%)

58,867.70 -480.00 ( -0.81%)

36,885.35 -157.95 ( -0.43%)

46,275.21 501.96 (1.10%)

6,624.30 64.54 (0.98%)

48,653.14 -1,170.80 (-2.35%)

9,535.95 8.30 (0.09%)

88.50 -0.07 (-0.08%)

102.33 -0.31 (-0.31%)

115.99 -0.49 (-0.42%)

0.57 0.00 (-0.62%)